Remove Biomarkers Remove Reimbursement Remove Technology
article thumbnail

Cardiac Wire Q&A: ECG Automation’s Care Impact

CardiacWire

Jimenez: Accucardia is an ECG-led diagnostics company, leveraging ECG as a broad biomarker for cardiology and beyond. Some cardiac monitoring companies have also outsourced these interpretations to cardiac technicians outside of the US in order to manage their increasing volumes and offset margin pressures from reimbursement rate reductions.

article thumbnail

Biocardia Reports Positive Interim Results from Phase III Cardiamp Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure

DAIC

The data was presented today by Amish Raval , MD, Director of Clinical Cardiovascular Research and Professor of Medicine at the University of Wisconsin-Madison at the Technology and Heart Failure Therapeutics (THT) 2024 annual meeting. The CardiAMP HF II trial is expected to similarly secure CMS reimbursement.